Kardi Ai Raises CZK 130M Series A at CZK 600M Valuation

Callisto Health led the CZK 130M Series A at a CZK 600M valuation. Kardi Ai will expand ECG monitoring into India, UAE and Southeast Asia while validating predictive arrhythmia-risk models.